Bio
Hayley V. McMahon, MSPH, CPH (she/her) is an abortion scholar-advocate from rural Appalachia. She is currently a fourth-year doctoral student and Laney Fellow at Emory University’s Rollins School of Public Health, as well as a Doctoral Fellow at the Center for Reproductive Health Research in the Southeast (RISE), where her research uses qualitative and community-engaged methods to explore the connections between abortion misinformation and disinformation, stigma, and criminalization. Hayley is a proud first-generation college graduate who holds a BA in Cultural Anthropology from Duke University and an MSPH in Health Education and Health Communications from the Johns Hopkins Bloomberg School of Public Health. Her work has appeared in a number of scholarly journals and news outlets, including Health Equity, Obstetrics & Gynecology, American Journal of Public Health, Teen Vogue, and NPR. She was recently selected as a 2024 Emerging Scholar in Family Planning by the Society of Family Planning and as the 2025 recipient of the Roger and Susan Rochat GEMMA Endowment Scholarship. In addition to her role as a public health scientist, Hayley is also an abortion fund board member, a clinic escort, and a former abortion care worker.
Areas of Interest
- Community Based Research
- Health Communication
- Health Literacy
- Rural Health
- Health Education
- Public Health Policy
- Reproductive Health
- Social Determinants of Health
Education
- B.A., Cultural Anthropology, Duke University
- MSPH, Health Education and Health Communications, Johns Hopkins Bloomberg School of Public Health
In The News
Rollins Research Review: Medication Abortion Knowledge, Pollen and Cardiovascular Disease, and Cost-Effectiveness of Cancer Screening
Summaries of a handful of research articles published by Rollins faculty in open access publications recently.
Experts Offer Vital Insights on Mifepristone Safety, Efficacy, and Access
On March 26, the U.S. Supreme Court will hear oral arguments in a case that could limit access to mifepristone, a drug primarily used in medication abortion. Researchers from the Center for Reproductive Health Research in the Southeast weigh in on the state of mifepristone access, the potential implications of this case, and what the public needs to know.